JDRF Blog
JDRF Blog
Information on research, events, activities, and news from the T1D community across Canada.
Advocate Profile: Ashlynn O'Hara and not backing down from the #AccessforAll fight
Ashlynn O’Hara is 10 years old, lives with type 1 diabetes (T1D), and is taking her fight for affordable continuous glucose monitors (CGM) to the big leagues.
The 2019 Ontario Budget: How to turn disappointment into action
The results of the Ontario budget mean that your voice is now more important than ever. You can immediately support this initiative by writing, calling or meeting with your provincial or territorial representative by simply clicking here.
The impact of your story: How #AccessforAll is more successful when T1D stories are shared
Having someone with the lived experience of diabetes relate their struggles with maintaining good blood glucose to political representatives and get across just how life-changing, in some cases life-saving, CGM and FGM devices can be, changes the whole conversation.
The Edmonton Protocol: JDRF celebrates 20th anniversary of first islet transplant
This month, twenty years ago, a pioneering clinical trial in Alberta marked a major advancement in islet transplantation for the treatment of type 1 diabetes (T1D).
JDRF Canada welcomes new Chief Scientific Officer, Dr. Sarah Linklater
We are pleased to announce Dr. Sarah Linklater has been appointed as Chief Scientific Officer (CSO).
New test offers better insight into genetic risk of type 1 diabetes in people of African descent
Recently, a team of researchers in the United States developed a test to identify individuals of African descent who are more likely to get the disease.
A JDRF legacy lives on with the Dr. Robert Goldstein Award
Dr. Esteban N. Gurzov, a talented young scientist from Brussels, Belgium, was recently named the first recipient of JDRF’s Dr. Robert Goldstein Award.
Paying it forward through research: From trial participant to T1D advocate
From Walk participant to trial participant to T1D advocate, here is Ash Hunkin's story.
New Quebec registry tracks hypoglycemia among diabetes patients to help reduce risks
Dr. Rémi Rabasa-Lhoret, a JDRF-funded endocrinologist at the Institut de recherches cliniques de Montréal best known for his work on the artificial pancreas, is overseeing the initiative to collect data for the Quebec-wide registry of people with T1D in order to track the incidence of ...
Studying the role of Vitamin D in the risk of type 1 diabetes
Does Vitamin D play a role in developing type 1 diabetes (T1D)?
